Put companies on watchlist
Kenvue
ISIN: US49177J1025
WKN: A3EEHU
Curious about what AI knows about Kenvue? Just one click more
More AI Integrations
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Kenvue · ISIN: US49177J1025 · Business Wire (ID: 20250424595295)
24 April 2025 12:45PM

Kenvue to Announce First Quarter 2025 Results on May 8, 2025


Kenvue Inc. (NYSE: KVUE) will announce its first quarter 2025 financial results before market open on May 8, 2025.

The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from international locations. A live webcast of the conference call can also be accessed at investors.kenvue.com, with a replay made available after the live event.

About Kenvue

Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.

Contact

Investor Relations:
Sofya Tsinis
Kenvue_IR@Kenvue.com

Media Relations:
Melissa Witt
Media@Kenvue.com

Visual performance / price development - Kenvue
Smart analysis and research tools can be found here.
MIC: XNYS
This publication was provided by our content partner Business Wire
BusinessWire
via BusinessWire - Newsfeed
BusinessWire ©2025
BusinessWire
Contact:
101 California Street, 20th Floor San Francisco, CA, 94111 United States
+1.415.986.4422